The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Tech boosts Nasdaq, S&P as Treasury yields dip further

Thu, 08th Apr 2021 16:02

(Updates to U.S. market open, changes byline, dateline;
previous LONDON)

By Stephen Culp

NEW YORK, April 8 (Reuters) - A tech-led rally pushed Wall
Street higher on Thursday and Treasury yields extended their
pull-back from recent peaks as market participants digested the
U.S. Federal Reserve's pledge to stay the course with its dovish
monetary policy.

The Nasdaq was sharply higher while the S&P 500, while up
more modestly, was on track to notch another record high. But
the blue-chip Dow was in the red, though only slightly, weighed
down by financials and industrials.

European stocks touched all-time highs on growing optimism
about a global stimulus-driven economic revival and reassurances
from the Fed. Emerging market stocks and equities
in Asia, aside from Japan, also rose.

"The momentum for stocks will continue largely because of
the stimulus that's been brought into the economy and the
multiplier effects that will continue to keep the economy
going," said Bernard Baumohl, managing director and chief global
economist at the Economic Outlook Group in Princeton, New
Jersey. "The returns in the stock market will be better than
fixed income."

Tech- and tech-adjacent market leaders, which outperformed
throughout the global health crisis, once again led the rally.

"The demand for tech will remain strong even as the economy
recovers," Baumohl added. "(Many workers) will continue to work
remotely and the drop-off in corporate travel will also be lost
for ever."

Minutes of the Fed's last policy meeting, published on
Wednesday, showed board members felt the economy was still short
of target and reiterated their accommodative monetary stance.

Fed Chairman Jerome Powell is due to speak on Thursday at an
International Monetary Fund event, where he is expected to
reiterate the central bank's dovish outlook.

A report from the U.S. Labor Department showed jobless
claims unexpectedly increased last week, a blemish among a
string of otherwise upbeat recent economic data.

The Dow Jones Industrial Average fell 34.39 points,
or 0.1%, to 33,411.87, the S&P 500 gained 8.18 points, or
0.20%, to 4,088.13 and the Nasdaq Composite added 96.58
points, or 0.71%, to 13,785.42.

The pan-European STOXX 600 index rose 0.45% and
MSCI's gauge of stocks across the globe gained
0.30%.

Emerging market stocks rose 0.28%. MSCI's broadest index of
Asia-Pacific shares outside Japan closed 0.53%
higher, while Japan's Nikkei lost 0.07%.

U.S. Treasury yields fell on Thursday, pressured by
weaker-than-expected initial weekly jobless claims and continued
short-covering following a sell-off in the last month that took
benchmark 10-year rates to more than one-year peaks.

Benchmark 10-year notes last rose 2/32 in price
to yield 1.6474%, from 1.654% late on Wednesday.

The 30-year bond last /32 in price to yield
2.3362%, from 2.336% late on Wednesday.

The dollar edged lower against a basket of currencies,
tracking Treasury yields and hovering near a two-week low.

The dollar index fell 0.32%, with the euro up
0.24% to $1.1899.

The Japanese yen strengthened 0.55% versus the greenback at
109.27 per dollar, while Sterling was last trading at
$1.3731, down 0.02% on the day.

Crude oil prices were weighed down by jump in U.S. gasoline
stocks, as demand remained sluggish despite signs of an economic
rebound.

U.S. crude fell 0.77% to $59.31 per barrel and Brent
was last at $62.88, down 0.44% on the day.

Gold prices jumped, scaling a one-month peak as the Fed's
assurances that its accommodative policy will remain in place
weighed on Treasury yields and the greenback.

Spot gold added 1.0% to $1,755.28 an ounce.

(Reporting by Stephen Culp; additional reporting by Huw Jones;
Editing by Dan Grebler)

More News
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.